Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 158

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 158
---
700,000 995,362
Share price as of settlement date $ 1.28 1.91
Fair value of settlement shares $ 376,587 1,337,000 $ 1,713,587
Debt settled on May 16, 2023 $ ( 376,587 ( 889,000 $ ( 1,265,587
Loss on Debt Settlements $ - 448,000 $ 448,000

Conversion
of convertible note

On
January 16, 2024, the Company entered into a convertible loan agreement with Gilandi Limited (“ Gilandi”), under which Gilandi
agreed to lend $ 500,000 250,000 8 March 31, 2024 1.00 250,000 500,000 500,000

On
April 16, 2024, the Company and Affluence Resource Pte. Ltd., a Singapore company (“ Affluence”) entered into a convertible
loan agreement (the “ Convertible Loan Agreement 2”) pursuant to which Affluence has agreed to lend to the Company a convertible
loan in the principal amount of $ 1,000,000 500,000 12 April 30, 2025 Anytime on or before May 31, 2024, Affluence may send the Company
a Conversion Notice to convert the then Outstanding Sum into ordinary shares of the Company at $1.00 per share. Anytime after May 31,
2024, Affluence may send the Company a Conversion Notice to convert the then Outstanding Sum into ordinary shares of the Company at $1.42
per share. The Company has no right of early repayment of any part of the Affluence Convertible Loan without Affluence’s written
consent. Any Outstanding Sum on the Maturity Date will be automatically converted into ordinary shares of the Company at $1.42 per share. 1,000,000 1,000,000

In
connection with the closing of the Business Combination, the Company issued to Maxim Group LLC (the “ Holder”) a
convertible promissory note in the aggregate amount of $ 2,113,125 1.5 1,408,750

Settlement
of Prepaid Forward Contracts

The
Company issued 1,600,000 2,368,000 1.48

Issuance
of ordinary shares in assets acquisition

On
May